Academician
ÖZGE AKBULUT ÇALIŞKAN
Doktor Öğretim Üyesi
Başkent Üniversitesi Fen-Edebiyat Fakültesi Moleküler Biyoloji Ve Genetik Bölümü
- Microtubule and mitosis dynamics7
- Cancer-related Molecular Pathways6
- Microbial metabolism and enzyme function4
- HER2/EGFR in Cancer Research4
- Cancer, Hypoxia, and Metabolism4
- Cancer Genomics and Diagnostics4
- Epigenetics and DNA Methylation4
- Microfluidic and Bio-sensing Technologies2
- Ubiquitin and proteasome pathways2
- Monoclonal and Polyclonal Antibodies Research2
- Colorectal Cancer Treatments and Studies1
- Microwave and Dielectric Measurement Techniques1
- Ana Dal Fen Bilimleri ve Matematik Temel Alanı
- Yan Dal Moleküler Biyoloji ve Genetik
Citation impact
Citation counts of the articles matched in OpenAlex, citing publications from Crossref and the Stanford/Elsevier list. Sources are shown separately and never added up.
- i10-index
- 9
- Total citations
- 739 Top 7.3% in Türkiye
- Per article
- 37.0
- FWCI
- 4.86 1.00 = world average
- World top 1%
- 2
- World top 10%
- 7
Most cited articles
- Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
- Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer
- Universality of dissipative self-assembly from quantum dots to human cells
How is this computed?
h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.
Citing publications Crossref 134 publications citing 20 DOI-bearing articles · 4 Türkiye-affiliated
- 2019 4
- 2020 27
- 2021 54
- 2022 21
- 2025 19
- 2026 9
- DOI 10.1016/j.colsurfb.2025.115360 2026
- DOI 10.1016/j.critrevonc.2025.105015 2026
- DOI 10.1016/j.physd.2025.135080 2026
- DOI 10.1016/j.ymthe.2025.10.053 2026
- DOI 10.1016/j.ejcb.2025.151527 2026
- DOI 10.1016/j.bioadv.2025.214635 2026
- DOI 10.1109/mmm.2025.3630092 2026
- DOI 10.1016/j.identj.2025.109298 2026
- DOI 10.1016/j.cej.2025.171346 2026
- DOI 10.1186/s13287-025-04743-2 2025
- DOI 10.1007/s12672-025-04182-8 2025
- DOI 10.1186/s12935-025-04064-7 2025
- DOI 10.1038/s41598-025-20463-2 2025
- DOI 10.3390/bios15110726 2025
- DOI 10.1021/cbmi.5c00143 2025
- DOI 10.1186/s11658-025-00806-7 2025
- DOI 10.3389/fimmu.2025.1678907 2025
- DOI 10.1007/s00280-025-04848-8 2025
- DOI 10.62347/sqpz5153 2025
- DOI 10.1016/j.ymthe.2025.12.021 2025
- DOI 10.1016/j.celrep.2025.116476 2025
- DOI 10.1016/j.ecoenv.2025.119303 2025
- DOI 10.1016/j.sna.2025.117190 2025
- DOI 10.1177/15330338251389551 2025
- DOI 10.1021/acs.chemrev.5c00644 2025
- DOI 10.20517/cdr.2025.148 2025
- DOI 10.1158/0008-5472.can-25-1904 2025
- DOI 10.1186/s40364-025-00854-3 2025
- DOI 10.32604/biocell.2022.018221 2022
- DOI 10.1016/j.gene.2021.146171 2022
Showing the 30 most recent.
Where does this list come from?
Extracted from the reference lists in Crossref’s public March 2026 data file; 20.3% of the file has been processed, so the list may be incomplete. Crossref citations are never added to or compared with the OpenAlex citation counts; the two sources have different coverage.
Field ranking
Position in the main-field, side-field and keyword cohorts by YÖKSİS article score; each card opens that ranking.
-
Main field Fen Bilimleri ve Matematik Temel AlanıPoints rank #3,442/ 11,969 top 28.8% At university #4/ 46Score 22.05 journal 19.8 · OA add 2.25
- Article rank5,873/11,969
- Scopus rank4,135/11,969
- WoS rank4,045/11,969
- YÖKSİS21
- Scopus20
- WoS20
-
Side field Moleküler Biyoloji ve GenetikPoints rank #143/ 765 top 18.7% At university #1/ 11Score 22.05 journal 19.8 · OA add 2.25
- Article rank228/765
- Scopus rank176/765
- WoS rank174/765
- YÖKSİS21
- Scopus20
- WoS20
Works 21
YÖKSİS and OpenAlex records: index distribution, journals published in, a filterable article list and the other output types.
Indexes and citation percentiles
?Other counts
Scopus (SJR)
- Excluding abstracts 10 Q1 8 Q2 2
- YÖKSİS rows 19
WoS (JCR)
- Excluding abstracts 10 Q1 8 Q3 2
- YÖKSİS rows 19
Articles
Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.
Journals with publications
11 journals
Narrow down
Article list
- 2026 Assessing the significance of CCNE1 overexpression in triple negative breast cancer YÖKSİS SJR Q2 JCR Q3 OpenAlex 59.7%
- 2025 Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy YÖKSİS OpenAlex 62.5%
- 2025 HER2-targeted therapy in colorectal cancer: a comprehensive review YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 98.7%
- 2024 Abstract LB275: Reactivation of mitotic arrest upon targeting TACC3 restores immunogenic cell death and T-DM1 response in HER2-positive breast cancer YÖKSİS SJR Q1 JCR Q1
- 2024 Abstract PO4-24-04: Identifying the interactome of TACC3, a major driver in aggressive cancer cells with centrosome amplification YÖKSİS SJR Q1 JCR Q1
- 2024 Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.3%
- 2023 Abstract 578: Novel bi-thiazole LOX inhibitors to overcome chemotherapy resistance in triple negative breast cancer YÖKSİS SJR Q1 JCR Q1
- 2023 High-Resolution Dielectric Characterization of Single Cells and Microparticles Using Integrated Microfluidic Microwave Sensors YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 94.7%
- 2023 Abstract P6-10-18: Developing novel lysyl oxidase (LOX) inhibitors to overcome chemotherapy resistance in triple negative breast cancer YÖKSİS SJR Q1 JCR Q1
- 2023 Abstract P4-08-20: Inhibition of TACC3 blocks the growth of highly aggressive breast cancers with centrosome amplification YÖKSİS SJR Q1 JCR Q1
- 2023 Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 96.5%
- 2023 Abstract 5728: Inhibition of TACC3 blocks the growth of highly aggressive breast cancers with centrosome amplification YÖKSİS SJR Q1 JCR Q1
- 2022 EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers YÖKSİS SJR Q1 JCR Q1 OpenAlex 68.2%
- 2021 Abstract LT015: Overcoming chemotherapy resistance in triple negative breast cancer via targeting lysyl oxidase (LOX) YÖKSİS SJR Q1 JCR Q1
- 2020 Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%
- 2020 Universality of dissipative self-assembly from quantum dots to human cells YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.7%
- 2020 A Highly Potent TACC3 Inhibitor as a Novel Anticancer Drug Candidate YÖKSİS SJR Q1 JCR Q1 OpenAlex 85.0%
- 2020 Microfluidics-Integrated Microwave Sensors for Single Cells Size Discrimination YÖKSİS OpenAlex 35.0%
- 2019 Abstract 3871: A novel TACC3 inhibitor as an anti-cancer agent in breast cancer YÖKSİS SJR Q1 JCR Q1
- 2018 A Novel TACC3 inhibitor as an anti-cancer agent in breast cancer YÖKSİS SJR Q1 JCR Q1
Projects 5
-
2023 HER2-pozitif kolon kanseri hücre hatlarında mikrosatelit stabilite durumuna göre Trastuzumab emtansine (T-DM1) ilacının sitotoksik etkisinin incelenmesi ve moleküler mekanizmasının belirlenmesi
-
2024 Doksorubisin ilacının meme kanseri hücrelerinde TACC3 ve ilgili yolaklara etkisinin belirlenmesi
-
2024 Kolorektal kanserinin farklı alt tiplerinde TACC3 gen/protein seviyelerinin tümör oluşumu üzerindeki etkilerinin belirlenmesi
-
2024 Klebsiella pneumoniae'nin Farklı Kapsüler Tiplerine Özgü Faj Türevli Depolimeraz Proteinin Tanımlanması ve Antimikrobiyal Etkinliğinin Değerlendirilmesi
-
2015 Erbb2-Pozitif Meme Kanserinde Sıralı Trastuzumab/T-Dm1 Direncinin Mekanizmasının In Vivo Ve In Vitro Modeller Kullanılarak Tesbiti Ve T-Dm1 Responsunu Artıracak Protein Hedeflerinin Belirlenmesi
Books 1
-
2022 Klinik araştırmalar
Proceedings 35 See all (35) →
-
— Elucidating the anticancer effects of Cabazitaxel and Quercetin on hsa-miR-646 levels and DNA methyltransferases in Prostate Cancer
-
— Investigating the Effects of Curcumin and Bromelain on hsa-miR-655-3p Expression and Necroptosis-Related Gene Expression in DU145 Cells
-
— Microfluidics-integrated microwave sensors for single cells size discrimination
-
— Developing novel lysyl oxidase (LOX) inhibitors to overcome chemotherapy resistance in triple negative breast cancer
-
— Novel bi-thiazole LOX inhibitors to overcome chemotherapy resistance in triple negative breast cancer
Patents 8 See all (8) →
-
— Isoxazole derivatives targeting TACC3 as anticancer agents JP7681018B2
-
— A highly potent TACC3 inhibitor as a novel anticancer drug candidate KR102797697B1
-
— Highly potent TACC3 inhibitor as a novel anticancer drug candidate US-11622966-B2
-
— HIGHLY POTENT TACC3 INHIBITOR AS A NOVEL ANTICANCER DRUG CANDIDATE EP3801529B1
-
— A highly potent TACC3 inhibitor as a novel anticancer drug candidate JP7301958B2
Collaboration network
From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.
- Co-authors
- 91
- With an akaturk profile
- 14
- Turkish institutions
- 6
- Co-authored works
- %100
Academic co-authors 14
- BURCU ÇALIŞKAN Profesör · Gazi Üniversitesi 8
- ERDEN BANOĞLU Profesör · Gazi Üniversitesi 8
- AYŞEGÜL ÜNER Profesör · Hacettepe Üniversitesi 6
- DENİZ LENGERLİ Doktor Öğretim Üyesi · Gazi Üniversitesi 6
- SERCAN AKSOY Profesör · Hacettepe Üniversitesi 6
- AYTEKİN AKYOL Profesör · Hacettepe Üniversitesi 4
- MERAL ÜNER Doktor Öğretim Üyesi · Hacettepe Üniversitesi 4
- KÜBRA ÇALIŞKAN Doktor Öğretim Üyesi · Gazi Üniversitesi 3
- MEHMET SELİM HANAY Doçent · İhsan Doğramacı Bilkent Üniversitesi 2
- AYŞE ELİF ERSON BENSAN Profesör · Orta Doğu Teknik Üniversitesi 1
Show all (14)
- AYŞEGÜL KAYMAK ÖZDEMİR Doktor Öğretim Üyesi · Ege Üniversitesi 1
- CAN ALKAN Doçent · İhsan Doğramacı Bilkent Üniversitesi 1
- NEVİN BELDER Öğretim Görevlisi (uygulamalı Birim) · Ankara Üniversitesi 1
- ÖMER DİZDAR Profesör · Hacettepe Üniversitesi 1
National collaboration 6 institutions
- Gazi Üniversitesi 8 works · 4 academics
- Hacettepe Üniversitesi 8 works · 5 academics
- İhsan Doğramacı Bilkent Üniversitesi 3 works · 2 academics
- Ankara Üniversitesi 1 works · 1 academics
- Ege Üniversitesi 1 works · 1 academics
- Orta Doğu Teknik Üniversitesi 1 works · 1 academics
Other co-authors (incl. international) 77
Özgür Şahin 19Özge Saatci 15METİN ÇETİN 8Vitali Sikirzhytski 6Abdol-Hossein Rezaeian 3Campbell McInnes 3Stefan Wiemann 3Arda Seçme 2Aynur Isik 2Carolyn E. Banister 2Dilara H. Uslu 2Elif Duman 2Elizabeth C. O’Quinn 2Hadi Sedaghat Pisheh 2Martin J. Romeo 2Mert Kaya Aras 2Mikhail Chernov 2Mustafa E. Gedik 2Nathaniel Oberholtzer 2Pelin Gülizar Ersan 2Phillip J. Buckhaults 2R. Tufan Erdogan 2Shikhar Mehrotra 2Umar Raza 2Urartu O.S. Seker 2Yasser Riazalhosseini 2AYŞEGÜL SAPMAZAyca CircirBerk KüçükoğluBreanna PedersonBurak SarıChad BenekerChaemin LimDidem DedeDidem Naz DiokenE. Doruk EnginErol EyüpoğluEsra CicekFATİH ÖMER İLDAYFatma Gundogdu
Show all (77)
Filiz Susuz AlanyalıGamze AykutGhaith MakeyGökhan YıldırımH. Volkan DemirHamed Shateri NajafabadiHarrison TaylorHashim AlhmoudHayriye Tatli DoganHelin ArikanHuib OvaaIoulia ChatzistamouKemal KosemehmetogluKıvanç GüngörMehmet DoganMerve OykenNageswara Rao ChintadaNigar Pelin MakasOnurcan BektaşPeggi AngelPouria JandaghiRengul Cetin-AtalayRoujin GhaffariSELVİ DURMUŞ ERİMSerim IldaySezen Guntekin ErgunSezin GaliogluSimone BorgoniSridhar VempatiSuhail A. AnsariSusan LessnerUnal Metin TokatUzay TefekYeliz BenliÖZGÜR KÜTÜKÖzgün YavuzÜ. Seleme Nizam
Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.